Elise Arrive

Summary

Country: France

Publications

  1. ncbi HIV status disclosure and retention in care in HIV-infected adolescents on antiretroviral therapy (ART) in West Africa
    Elise Arrive
    INSERM, ISPED, Centre INSERM U 897 Epidemiologie Biostatistique, Bordeaux, France
    PLoS ONE 7:e33690. 2012
  2. ncbi Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis
    Elise Arrive
    Unité INSERM 593, Bordeaux, France
    Int J Epidemiol 36:1009-21. 2007
  3. ncbi Maternal and nenonatal tenofovir and emtricitabine to prevent vertical transmission of HIV-1: tolerance and resistance
    Elise Arrive
    INSERM U897, Universite Victor Segalen Bordeaux 2, 33076 Bordeaux Cedex, France
    AIDS 24:2481-8. 2010
  4. ncbi Universal antiretroviral therapy for pregnant and breast-feeding HIV-1-infected women: towards the elimination of mother-to-child transmission of HIV-1 in resource-limited settings
    Renaud Becquet
    INSERM, Unité 897, Centre de Recherche Epidémiologie et Biostatistique, Bordeaux, France
    Clin Infect Dis 49:1936-45. 2009
  5. ncbi [Survival, clinical and biological outcomes of HIV-infected children treated by antiretroviral therapy in Africa: systematic review, 2004-2009]
    Camille Ndondoki
    Universite Victor Segalen Bordeaux 2, Institut de Santé Publique, d Epidémiologie et de Développement ISPED, 33076 Bordeaux, France
    Presse Med 40:e338-57. 2011
  6. ncbi Cohort profile: the paediatric antiretroviral treatment programmes in lower-income countries (KIDS-ART-LINC) collaboration
    Elise Arrive
    Unité INSERM 593, Institut de Santé Publique, Epidémiologie et Développement ISPED, Universite Victor Segalen, Bordeaux, France
    Int J Epidemiol 37:474-80. 2008
  7. ncbi Correlates of adherence to antiretroviral therapy in HIV-infected children in Lomé, Togo, West Africa
    Julie Polisset
    Institut de Santé Publique, d Epidémiologie et de Développement ISPED, Universite Victor Segalen Bordeaux 2, Case 11, 146 rue Leo Saignat, 33076, Bordeaux Cedex, France
    AIDS Behav 13:23-32. 2009

Detail Information

Publications7

  1. ncbi HIV status disclosure and retention in care in HIV-infected adolescents on antiretroviral therapy (ART) in West Africa
    Elise Arrive
    INSERM, ISPED, Centre INSERM U 897 Epidemiologie Biostatistique, Bordeaux, France
    PLoS ONE 7:e33690. 2012
    ..We assessed the effect of HIV status disclosure on retention in care from initiation of antiretroviral therapy (ART) among HIV-infected children aged 10 years or more in Cote d'Ivoire, Mali and Sénégal...
  2. ncbi Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis
    Elise Arrive
    Unité INSERM 593, Bordeaux, France
    Int J Epidemiol 36:1009-21. 2007
    ..This systematic review and meta-analysis of summarized data aimed to estimate the proportion of mothers and children with NVP resistance mutations detected in plasma samples 4-8 weeks postpartum after single-dose NVP use for PMTCT...
  3. ncbi Maternal and nenonatal tenofovir and emtricitabine to prevent vertical transmission of HIV-1: tolerance and resistance
    Elise Arrive
    INSERM U897, Universite Victor Segalen Bordeaux 2, 33076 Bordeaux Cedex, France
    AIDS 24:2481-8. 2010
    ..We aimed to evaluate the tolerance and resistance profiles of a combination of tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) given to HIV-1-infected delivering women and their newborns...
  4. ncbi Universal antiretroviral therapy for pregnant and breast-feeding HIV-1-infected women: towards the elimination of mother-to-child transmission of HIV-1 in resource-limited settings
    Renaud Becquet
    INSERM, Unité 897, Centre de Recherche Epidémiologie et Biostatistique, Bordeaux, France
    Clin Infect Dis 49:1936-45. 2009
    ..On the basis of available evidence, we suggest translating into practice the recently available evidence on this matter without any further delay...
  5. ncbi [Survival, clinical and biological outcomes of HIV-infected children treated by antiretroviral therapy in Africa: systematic review, 2004-2009]
    Camille Ndondoki
    Universite Victor Segalen Bordeaux 2, Institut de Santé Publique, d Epidémiologie et de Développement ISPED, 33076 Bordeaux, France
    Presse Med 40:e338-57. 2011
    ..This paper aims to review the effectiveness of cotrimoxole prophylaxis and antiretroviral treatment in HIV-infected children in Africa, specifically mortality and treatment outcomes...
  6. ncbi Cohort profile: the paediatric antiretroviral treatment programmes in lower-income countries (KIDS-ART-LINC) collaboration
    Elise Arrive
    Unité INSERM 593, Institut de Santé Publique, Epidémiologie et Développement ISPED, Universite Victor Segalen, Bordeaux, France
    Int J Epidemiol 37:474-80. 2008
  7. ncbi Correlates of adherence to antiretroviral therapy in HIV-infected children in Lomé, Togo, West Africa
    Julie Polisset
    Institut de Santé Publique, d Epidémiologie et de Développement ISPED, Universite Victor Segalen Bordeaux 2, Case 11, 146 rue Leo Saignat, 33076, Bordeaux Cedex, France
    AIDS Behav 13:23-32. 2009
    ....